Ozempic's Rise May Widen Health Inequalities, Scientists Warn

Scientists warn that the widespread use of Ozempic for obesity could exacerbate health inequalities, as access may be uneven. The claim is based on expert commentary rather than new data, and the specific mechanisms remain unclear. This matters because it could influence public health policy and drug pricing debates.